Search for: "A&J Manufacturing, Inc."
Results 561 - 580
of 1,721
Sort by Relevance
|
Sort by Date
8 Oct 2015, 5:00 am
Caraco Pharmaceutical, Inc., 670 F. [read post]
21 Sep 2015, 5:38 pm
DOUGLAS J. [read post]
15 Sep 2015, 5:53 am
“Investigators of Anthem Inc. [read post]
14 Sep 2015, 7:41 am
Another recent example is BCCA Appeal Group, Inc. v. [read post]
30 Aug 2015, 11:32 am
Textron, Inc., No. 3:10 CV 87, 2014 U.S. [read post]
28 Aug 2015, 3:05 pm
The consolidated federal case is In re DePuy Orthopedics Inc., ASR Hip Implant Products Liability Litigation, 10-MD-2197, U.S. [read post]
27 Aug 2015, 7:14 am
Teva Parenteral Medicines, Inc., et al, 1-10-cv-01376 (INSD August 25, 2015, Order) (Pratt, J.) [read post]
13 Aug 2015, 10:56 am
§355(j)(2)(A). [read post]
7 Aug 2015, 5:20 am
Kehoe Component Sales Inc. v. [read post]
5 Aug 2015, 6:56 am
Leviton Manufacturing Co., Inc., 1-10-cv-01020 (NMD August 3, 2015, Order) (Browning, J.) [read post]
31 Jul 2015, 3:00 am
Honda of America Manufacturing, Inc. [read post]
30 Jul 2015, 11:29 am
The consolidated federal case is In re DePuy Orthopedics Inc., ASR Hip Implant Products Liability Litigation, 10-MD-2197, U.S. [read post]
27 Jul 2015, 6:25 am
Honda of America Manufacturing, Inc. [read post]
22 Jul 2015, 12:40 pm
§ 55(j)(2)(A)(vii)(IV), with respect to the '209 patent, asserting that the claims of the '209 patent are invalid, unenforceable, and/or not infringed by the manufacture, use, offer for sale, or sale of Defendants' ANDA products. [read post]
22 Jul 2015, 3:56 am
James Flaws, Corning Inc. [read post]
12 Jul 2015, 10:44 am
” Cornelia J. [read post]
10 Jul 2015, 10:45 am
& J. [read post]
10 Jul 2015, 4:30 am
CV-13-J-1357-NE, 2014 U.S. [read post]
1 Jul 2015, 4:30 am
Conagra Foods, Inc., 2014 U.S. [read post]
30 Jun 2015, 3:50 am
Another two were killed off as reported here (some claims survived in one patent, but these are apparently not of concern to Hospira); this is currently under appeal.The present case Hospira UK Ltd v Genentech Inc [2015] EWHC 1796 (Pat) concerns EP (UK) 1037926, which concerns a combination of trastuzumab with another favourite of pharmaceutical litigation, taxol (and other taxanes). [read post]